RxSouthJune 26, 2019

FDA 145 - RxSouth - June 26, 2019

FDA 145 for RxSouth on June 26, 2019. Product: Drugs. Access full analysis and detailed observations.

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA 145 for RxSouth on June 26, 2019. Product: Drugs. Access full analysis and detailed observations.

Violation Codes

FD&C Act 801(a)(3)

21 U.S.C. 331(a)

21 CFR 211

21 CFR 210

21 CFR 314.80

21 U.S.C. 351(a)(2)(B)

21 CFR 320

21 U.S.C. 351(d)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

RxSouth

Inspection Date

June 26, 2019

Product Type

Drugs

People

Craig W. Swanson (Deputy District Director)

ID: cec1293e-c3fa-43a4-ba1c-66ff9033e80c

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox